---
title: "Design Therapeutics (DSGN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DSGN.US/norm.md"
symbol: "DSGN.US"
name: "Design Therapeutics"
parent: "https://longbridge.com/en/quote/DSGN.US.md"
datetime: "2026-05-19T14:14:06.948Z"
locales:
  - [en](https://longbridge.com/en/quote/DSGN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DSGN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DSGN.US/norm.md)
---

# Design Therapeutics (DSGN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2871 | -0.2724 | -0.2984 | -0.3356 | -0.3121 |
| ROE | -32.77% | -31.05% | -32.94% | -34.62% | -30.15% |
| Revenue | - | - | - | - | - |
| Net income | -17.64M | -16.00M | -17.00M | -19.08M | -17.71M |
| Operating income | -19.71M | -18.17M | -19.31M | -21.57M | -20.42M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 230.44M | 226.20M | 211.77M | 222.89M | 237.47M |
| Leverage | 1.06 | 1.06 | 1.06 | 1.05 | 1.04 |
| BVPS | 3.49 | 3.52 | 3.51 | 3.74 | 4.01 |
| Turnover | - | - | - | - | - |
| Cash & STI | 222.82M | 219.84M | 205.97M | 216.28M | 229.67M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.39M | 2.42M | 2.74M | 3.09M | 3.40M |
| Net debt | -220.09M | -218.31M | -204.23M | -214.33M | -227.53M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -16.43M | -11.97M | -11.16M | -14.44M | -16.79M |
| Investing CF | -7.59M | -11.58M | 6.51M | 20.12M | 7.87M |
| Financing CF | 19.93M | 25.32M | 37000.00 | 361000.00 | 23000.00 |
| Free CF | -11.03M | -6.82M | -5.46M | -8.49M | -10.79M |
| OCF coverage | - | -35194.12% | - | -16598.85% | -23318.06% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | -34000.00 | 0.0000 | -87000.00 | -72000.00 |